Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 85
13
Diseases
17
Unique genes
0.284
Avg. similarity score
Paroxysmal dystonic choreoathetosis
Most-connected disease (9 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Paroxysmal dystonic choreoathetosis
Episodic kinesigenic dyskinesia
Paroxysmal nonkinesigenic dyskinesia
Familial infantile convulsions with paroxysmal choreoathetosis
Paroxysmal dyskinesia
Childhood-onset glut1 deficiency syndrome 2
Hereditary continuous muscle fiber activity
Paroxysmal dystonia
episodic ataxia type 1
infantile convulsions and choreoathetosis
Cerebellar atrophy with seizures and variable developmental delay
generalized epilepsy-paroxysmal dyskinesia syndrome
complex neurodevelopmental disorder with motor features
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Paroxysmal dystonic choreoathetosis | 9 | 9 | 4 |
| Episodic kinesigenic dyskinesia | 8 | 8 | 3 |
| Paroxysmal nonkinesigenic dyskinesia | 8 | 8 | 4 |
| Familial infantile convulsions with paroxysmal choreoathetosis | 6 | 6 | 1 |
| Paroxysmal dyskinesia | 6 | 6 | 5 |
| Childhood-onset glut1 deficiency syndrome 2 | 5 | 5 | 2 |
| Hereditary continuous muscle fiber activity | 5 | 5 | 1 |
| Paroxysmal dystonia | 5 | 5 | 1 |
| episodic ataxia type 1 | 5 | 5 | 1 |
| infantile convulsions and choreoathetosis | 5 | 5 | 1 |
| Cerebellar atrophy with seizures and variable developmental delay | 3 | 3 | 5 |
| generalized epilepsy-paroxysmal dyskinesia syndrome | 2 | 2 | 1 |
| complex neurodevelopmental disorder with motor features | 1 | 1 | 6 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| PRRT2 | 8 / 13 | Childhood-onset glut1 deficiency syndrome 2, Episodic kinesigenic dyskinesia, Familial infantile convulsions with paroxysmal choreoathetosis, infantile convulsions and choreoathetosis and 4 more |
| KCNA1 | 6 / 13 | episodic ataxia type 1, Episodic kinesigenic dyskinesia, Hereditary continuous muscle fiber activity, Paroxysmal dyskinesia and 2 more |
| KCNMA1 | 3 / 13 | Cerebellar atrophy with seizures and variable developmental delay, generalized epilepsy-paroxysmal dyskinesia syndrome, Paroxysmal nonkinesigenic dyskinesia |
| SLC2A1 | 3 / 13 | Childhood-onset glut1 deficiency syndrome 2, Paroxysmal dyskinesia, Paroxysmal dystonic choreoathetosis |
| EMC1 | 2 / 13 | Cerebellar atrophy with seizures and variable developmental delay, complex neurodevelopmental disorder with motor features |
| KCNJ10 | 2 / 13 | Paroxysmal dyskinesia, Paroxysmal dystonic choreoathetosis |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Presynaptic depolarization and calcium channel opening | Reactome | 2 / 12 | 118× | 1.23e-4 | 2.66e-3 ✓ sig. |
| Regulation of insulin secretion | Reactome | 2 / 16 | 88.3× | 2.24e-4 | 4.28e-3 ✓ sig. |
| Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1) | Reactome | 1 / 1 | 706× | 1.42e-3 | 1.76e-2 ✓ sig. |
| Enzymatic degradation of Dopamine by monoamine oxidase | Reactome | 1 / 2 | 353× | 2.83e-3 | 2.95e-2 ✓ sig. |
| Enzymatic degradation of dopamine by COMT | Reactome | 1 / 3 | 235× | 4.24e-3 | 3.93e-2 ✓ sig. |
| Lactose synthesis | Reactome | 1 / 3 | 235× | 4.24e-3 | 3.93e-2 ✓ sig. |
| Potassium transport channels | Reactome | 1 / 3 | 235× | 4.24e-3 | 3.93e-2 ✓ sig. |
| Insulin secretion | KEGG | 2 / 86 | 16.4× | 6.43e-3 | 5.17e-2 |
| Pancreatic secretion | KEGG | 2 / 102 | 13.9× | 8.94e-3 | 6.42e-2 |
| Vitamin C (ascorbate) metabolism | Reactome | 1 / 8 | 88.3× | 1.13e-2 | 7.36e-2 |
| Ca2+ activated K+ channels | Reactome | 1 / 9 | 78.5× | 1.27e-2 | 7.87e-2 |
| Dopaminergic synapse | KEGG | 2 / 132 | 10.7× | 1.46e-2 | 8.58e-2 |
| Methylation | Reactome | 1 / 14 | 50.5× | 1.96e-2 | 1.02e-1 |
| VxPx cargo-targeting to cilium | Reactome | 1 / 21 | 33.6× | 2.93e-2 | 1.27e-1 |
| Cellular hexose transport | Reactome | 1 / 21 | 33.6× | 2.93e-2 | 1.27e-1 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| monoatomic ion transmembrane transport | GO:0034220 | 5 / 404 | 13.6× | 2.30e-5 | 9.99e-4 ✓ sig. |
| regulation of membrane potential | GO:0042391 | 3 / 85 | 38.8× | 5.90e-5 | 2.03e-3 ✓ sig. |
| neuromuscular process controlling posture | GO:0050884 | 2 / 15 | 147× | 8.12e-5 | 2.59e-3 ✓ sig. |
| transmembrane transport | GO:0055085 | 5 / 557 | 9.9× | 1.06e-4 | 3.16e-3 ✓ sig. |
| regulation of long-term neuronal synaptic plasticity | GO:0048169 | 2 / 18 | 122× | 1.18e-4 | 3.43e-3 ✓ sig. |
| startle response | GO:0001964 | 2 / 18 | 122× | 1.18e-4 | 3.43e-3 ✓ sig. |
| monoatomic ion transport | GO:0006811 | 5 / 667 | 8.2× | 2.47e-4 | 5.88e-3 ✓ sig. |
| potassium ion transmembrane transport | GO:0071805 | 3 / 150 | 22.0× | 3.17e-4 | 7.00e-3 ✓ sig. |
| potassium ion transport | GO:0006813 | 3 / 152 | 21.7× | 3.30e-4 | 7.17e-3 ✓ sig. |
| response to hypoxia | GO:0001666 | 3 / 176 | 18.7× | 5.07e-4 | 9.66e-3 ✓ sig. |
| catecholamine catabolic process | GO:0042424 | 1 / 1 | 1,099× | 9.10e-4 | 1.42e-2 ✓ sig. |
| norepinephrine secretion | GO:0048243 | 1 / 1 | 1,099× | 9.10e-4 | 1.42e-2 ✓ sig. |
| response to dopamine | GO:1903350 | 1 / 1 | 1,099× | 9.10e-4 | 1.42e-2 ✓ sig. |
| synaptic vesicle endosomal processing | GO:0099532 | 1 / 1 | 1,099× | 9.10e-4 | 1.42e-2 ✓ sig. |
| negative regulation of short-term synaptic potentiation | GO:1905513 | 1 / 1 | 1,099× | 9.10e-4 | 1.42e-2 ✓ sig. |